In Brazil, Zion Market Research predicts that the biomaterials market will grow significantly from the 2016 level of $1.89 billion to more than $5.18 billion by 2022. The report says that much of the biomaterials growth in Brazil will be in the healthcare industry which has been growing tremendously lately. The healthcare industry growth in Brazil is mostly due to a larger aging population, low cost health care, favorable government regulations, and a high quality level of care boosting medical tourism in the country. The report points out that Brazil is the fifth largest country in both land area and population, making it a huge market for biomaterials expansion. Companies like Allergan Inc., Biomet, In., Integra Life Sciences Holdings Corporation and others are listed as key medical biomaterials players in Brazil.
Latest article
Body-based burial: Students imagine urns made from blood and hair
In Slovenia, students at University of Ljubljana have used biobased materials for a variety of design projects, including a biodegradable urn made of blood...
Uttar Pradesh eyes cow poop plastics to boost rural economy
In Uttar Pradesh, a government project is collecting cow dung to convert into usable products such as bioplastics, textiles, and paper.
The Press Trust...
Luxury brand Velvet Eyewear lauds advances in biobased acetate
In California, luxury women’s eyewear brand Velvet Eyewear has unveiled its first biobased eyewear collection.
Crafted from renewable sources like wood pulp and cotton...